Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Briers, Erik" or (type any "bookEditor journalEditor issueEditor" and editor="Briers, Erik")

Add to list
- Journal Article
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst (UGent) , Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck, Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) Lung Cancer. p.228-241
Add to list
- Journal Article
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck (UGent) , et al.

(2022) Radiotherapy and Oncology. p.75-82
Add to list
- Journal Article
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, Andrea Manzoni, Anna Maria Paganoni, Paolo Zunino, Liv Veldeman (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Christopher J. Talbot, et al.

(2021) Radiotherapy and Oncology. p.241-248
Add to list
- Journal Article
- A1
- open access
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Ana Carballo, et al.

(2019) Radiotherapy and Oncology. 138. p.59-67

Academic Bibliography

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Contents

Support

Contact